Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care.

Q2 Biochemistry, Genetics and Molecular Biology
Stephanie Sibley, Clare Atzema, Martin Balik, Jonathan Bedford, David Conen, Tessa Garside, Brian Johnston, Salmaan Kanji, Camron Landry, William McIntyre, David M Maslove, John Muscedere, Marlies Ostermann, Frank Scheuemeyer, Andrew Seeley, Marco Sivilotti, Jennifer Tsang, Michael K Wang, Ingeborg Welters, Allan Walkey, Brian Cuthbertson
{"title":"Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care.","authors":"Stephanie Sibley, Clare Atzema, Martin Balik, Jonathan Bedford, David Conen, Tessa Garside, Brian Johnston, Salmaan Kanji, Camron Landry, William McIntyre, David M Maslove, John Muscedere, Marlies Ostermann, Frank Scheuemeyer, Andrew Seeley, Marco Sivilotti, Jennifer Tsang, Michael K Wang, Ingeborg Welters, Allan Walkey, Brian Cuthbertson","doi":"10.1186/s12919-024-00309-x","DOIUrl":null,"url":null,"abstract":"<p><p>Atrial fibrillation (AF) is a common arrhythmia encountered in acute and critical illness and is associated with poor short and long-term outcomes. Given the consequences of developing AF, research into prevention, prediction and treatment of this arrhythmia in the critically ill are of great potential benefit, however, study of AF in critically ill patients faces unique challenges, leading to a sparse evidence base to guide management in this population. Major obstacles to the study of AF in acute and critical illness include absence of a common definition, challenges in designing studies that capture complex etiology and assess causality, lack of a clear outcome set, difficulites in recruitment in acute environments with respect to timing, consent, and workflow, and failure to embed studies into clinical care platforms and capitalize on emerging technologies. Collaborative effort by researchers, clinicians, and stakeholders should be undertaken to address these challenges, both through interdisciplinary cooperation for the optimization of research efficiency and advocacy to advance the understanding of this common and complex arrhythmia, resulting in improved patient care and outcomes. The Symposium on Atrial Fibrillation in Acute and Critical Care was convened to address some of these challenges and propose potential solutions.</p>","PeriodicalId":9046,"journal":{"name":"BMC Proceedings","volume":"18 Suppl 22","pages":"23"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536622/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12919-024-00309-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Atrial fibrillation (AF) is a common arrhythmia encountered in acute and critical illness and is associated with poor short and long-term outcomes. Given the consequences of developing AF, research into prevention, prediction and treatment of this arrhythmia in the critically ill are of great potential benefit, however, study of AF in critically ill patients faces unique challenges, leading to a sparse evidence base to guide management in this population. Major obstacles to the study of AF in acute and critical illness include absence of a common definition, challenges in designing studies that capture complex etiology and assess causality, lack of a clear outcome set, difficulites in recruitment in acute environments with respect to timing, consent, and workflow, and failure to embed studies into clinical care platforms and capitalize on emerging technologies. Collaborative effort by researchers, clinicians, and stakeholders should be undertaken to address these challenges, both through interdisciplinary cooperation for the optimization of research efficiency and advocacy to advance the understanding of this common and complex arrhythmia, resulting in improved patient care and outcomes. The Symposium on Atrial Fibrillation in Acute and Critical Care was convened to address some of these challenges and propose potential solutions.

急危重症期间心房颤动研究的重点:急危重症心房颤动研讨会的建议。
心房颤动(房颤)是急危重症患者常见的心律失常,与短期和长期的不良预后有关。鉴于心房颤动的后果,对危重病人心律失常的预防、预测和治疗进行研究具有巨大的潜在益处,然而,危重病人心房颤动的研究面临着独特的挑战,导致用于指导该人群管理的证据基础稀缺。急危重症患者房颤研究面临的主要障碍包括:缺乏统一的定义;在设计可捕捉复杂病因和评估因果关系的研究时面临挑战;缺乏明确的结果集;急诊环境中的招募在时间、同意和工作流程方面存在困难;未能将研究嵌入临床护理平台并利用新兴技术。研究人员、临床医生和利益相关者应共同努力应对这些挑战,既要通过跨学科合作优化研究效率,又要通过宣传促进对这种常见而复杂的心律失常的了解,从而改善患者护理和治疗效果。召开 "急性和重症监护中的心房颤动 "研讨会就是为了应对其中的一些挑战并提出潜在的解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Proceedings
BMC Proceedings Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
3.50
自引率
0.00%
发文量
6
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信